James Edgemond

2019

In 2019, James Edgemond earned a total compensation of $16M as Chief Financial Officerand Treasurer at United Therapeutics, a 205% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,668,041
Non-Equity Incentive Plan$632,813
Option Awards$13,003,250
Salary$645,192
Other$19,600
Total$15,968,896

Edgemond received $13M in option awards, accounting for 81% of the total pay in 2019.

Edgemond also received $1.7M of change in pension value and nonqualified deferred compensation earnings, $632.8K in non-equity incentive plan, $645.2K in salary and $19.6K in other compensation.

Rankings

In 2019, James Edgemond's compensation ranked 298th out of 13,971 executives tracked by ExecPay. In other words, Edgemond earned more than 97.9% of executives.

ClassificationRankingPercentile
All
298
out of 13,971
98th
Division
Manufacturing
102
out of 5,701
98th
Major group
Chemicals And Allied Products
29
out of 2,200
99th
Industry group
Drugs
24
out of 1,886
99th
Industry
Pharmaceutical Preparations
20
out of 1,398
99th
Source: SEC filing on April 29, 2022.

Edgemond's colleagues

We found three more compensation records of executives who worked with James Edgemond at United Therapeutics in 2019.

2019

Martine Rothblatt

United Therapeutics

Chief Executive Officer

2019

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2019

Paul Mahon

United Therapeutics

General Counsel

News

In-depth

You may also like